Spiber Inc. Raises JPY 34.4 Billion In Funding To Strengthen Production And Sales Network
Utilizing investor Carlyle’s network to accelerate global commercialization
Spiber a biomanufacturing startup, announced that it has approved a capital increase of JPY 24.4 billion yen through an equity investment round which includes leading global investors such as Carlyle (Japan representative: Kazuhiro Yamada), as well as from existing shareholders such as Cool Japan Fund Inc. (President and CEO: Kenichi Kawasaki).
Spiber has simultaneously approved an additional JPY 10 billion capital raise through an extension of the value securitization structure executed as of December 28th, 2021 and arranged by Mitsubishi UFJ Morgan Stanley Securities Co., Ltd., bringing the new capital total to JPY 34.4 billion.
As a new investor, Carlyle has made a significant investment into Spiber, representing Carlyle’s first-ever non-buyout growth investment in Japan. Spiber will be able to fully leverage Carlyle’s global industry experience, sustainability expertise, and network with luxury brands as well as the textile and material industries to accelerate its further growth. Carlyle’s previous investments include sustainability-oriented companies such as Jeanologia and Beautycounter, as well as world-leading apparel brands like Moncler and Golden Goose.
Spiber will additionally receive a significant follow-on investment from existing Japan-based shareholder Cool Japan Fund, who has been strongly supporting Spiber since 2018. Moreover, global investors such as Fidelity International and Baillie Gifford, as well as domestic Spiber shareholders Tokyo Century, Yamagata Bank and Satake Chemical Equipment Mfg., will join this round. Cool Japan Fund and Carlyle will each send one director to serve on Spiber’s board and thus become the company’s domestic and global cornerstone investors. Leveraging the broad networks and deep expertise of these shareholders will allow Spiber to accelerate its global expansion projects, as well as further develop communication with domestic and global investors in preparation for an IPO within the next several years.
Recommended AI News: University of Saint Francis Selects Ellucian to Accelerate Technology Transformation
Mitsubishi UFJ Morgan Stanley and Anderson Mori Tomotsune acted as the financial and legal advisors respectively for this equity financing.
Spiber’s proprietary Brewed Protein material is a bio-based, biodegradable, and animal-free synthetic protein platform. It can be applied to substitutes for cashmere, wool, fur, leather, silk, and other animal and/or petroleum-based materials, and offers important environmental benefits such as significantly reduced natural resource consumption and the potential for lower GHG-emissions compared to cashmere production (based on Spiber’s preliminary LCA). With its unique, vertically-integrated R&D approach that delivers superior results in productivity and material features, Spiber is well-positioned to benefit from an increased ESG focus across industries, and to take the lead in the global bio-engineered sustainable material market. Spiber is also poised to begin implementing mass production through its plant in Thailand in 2021, and in the US as early as 2023.
Proteins are a core element of all life and ecosystems found on Earth. By building up the infrastructure needed to master production of these materials on an industrial level, Spiber is striving to solve global-scale issues and help bring about a more sustainable society.